Evidence map›Paper›PMID 34422148›Full record

ArticleRadiology case reports2021

Multiple cranial nerve palsies revealing blast crisis in patient with chronic myeloid leukemia in the accelerated phase under nilotinib during severe infection with SARS-COV-19 virus: Case report and review of literature.

Amine Bouchlarhem, Leila Haddar, Oussama Lamzouri, Onci-Es-Saad, Siham Nasri, Narjisse Aichouni, Houssam Bkiyar, Yassine Mebrouk, Imane Skiker, Brahim Housni

Open access · goldAbstract readCase Reports
In one paragraph

Article in Radiology case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. SARS-CoV-2 infection presenting as rhabdomyolysis: case report and review.The Journal of international medical research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Amine BouchlarhemFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Leila HaddarFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Oussama LamzouriFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Onci-Es-SaadFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Siham NasriFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Narjisse AichouniFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Houssam BkiyarFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Yassine MebroukFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Imane SkikerFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Brahim HousniFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Mohamed I University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the introduction of tyrosine kinase inhibitors as primary therapy for patients with chronic myeloid leukemia (CML), the prognosis of these patients has improved significantly, and the number of patients who progress to the blast phase has decreased considerably. We report the case of a 35 year-old CML patient in accelerated phase treated with nilotinib, who presents a severe COVID-19 infection requiring non-invasive ventilation, and who subsequently presents a multiple cranial nerve palsy revealing a blast crisis of his CML. Multiple cranial nerve palsy is a sign of neurological involvement of CML in its blast phase. The blast crisis represents a real challenge for the clinician, especially during COVID-19 infection. The treatment remains the association of a tyrosine kinase inhibitors with a chemotherapy protocol, as well as the administration of methotrexate and cytarabine by intrathecal and intravenous infusion in high doses. Despite the importance of the association of CML with COVID-19 infection, there is not yet enough data to know the true impact of this infection on the evolution of this hemopathy.

Indexed as

Blast CrisisChronic Myeloid LeukemiaCovid-19Cranial Nerve PalsyTyrosine Kinase Inhibitor

Identifiers

PMID34422148
PMCPMC8367734
OpenAlexW3195604410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.